CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells-Reference-Cited by-同舟云学术

CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells

Published:2009-03 Issue:2 Volume:2 Page:113-124
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Sundberg Maria,Jansson Linda,Ketolainen Johanna,Pihlajamäki Harri,Suuronen Riitta,Skottman Heli,Inzunza José,Hovatta Outi,Narkilahti Susanna

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference42 articles.

1. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas;Assou;Stem Cells,2007

2. In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133;Barraud;J. Neurosci. Res.,2007

3. Gene expression in human embryonic stem cell lines: unique molecular signature;Bhattacharya;Blood,2004

4. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency;Brimble;Stem Cells,2006

5. Development of antibodies to human embryonic stem cell antigens;Cai;BMC Dev. Biol.,2005

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CelltypeR: A flow cytometry pipeline to characterize single cells from brain organoids;iScience;2024-09

2. Short-Term Clinical Results of Single-Injection Autologous Bone Marrow Aspirate Concentrate (BMAC) as a Therapeutic Option/Tool in Knee Osteoarthritis;Biologics;2024-06-19

3. Regulation of the Function and Expression of EpCAM;Biomedicines;2024-05-20

4. Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron‐like cells;IUBMB Life;2024-04-25

5. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies;Frontiers in Oncology;2023-06-28